Literature DB >> 27821465

Effective Canadian policy to reduce harms from prescription opioids: learning from past failures.

Benedikt Fischer1, Jürgen Rehm2, Mark Tyndall2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27821465      PMCID： PMC5135494          DOI： 10.1503/cmaj.160356

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  59 in total

1.  High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.

Authors:  Benedikt Fischer; Wayne Jones; Jürgen Rehm
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-14       Impact factor: 2.890

2.  Trends in high-dose opioid prescribing in Canada.

Authors:  Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Irfan A Dhalla; David N Juurlink
Journal:  Can Fam Physician       Date:  2014-09       Impact factor: 3.275

3.  Project Lazarus: community-based overdose prevention in rural North Carolina.

Authors:  Su Albert; Fred W Brason; Catherine K Sanford; Nabarun Dasgupta; Jim Graham; Beth Lovette
Journal:  Pain Med       Date:  2011-06       Impact factor: 3.750

Review 4.  A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain.

Authors:  Laxmaiah Manchikanti; Hary Ailinani; Dhanalakshmi Koyyalagunta; Sukdeb Datta; Vijay Singh; Ike Eriator; Nalini Sehgal; Rinoo Shah; Ramsin Benyamin; Ricardo Vallejo; Bert Fellows; Paul J Christo
Journal:  Pain Physician       Date:  2011 Mar-Apr       Impact factor: 4.965

Review 5.  Opioid epidemic in the United States.

Authors:  Laxmaiah Manchikanti; Standiford Helm; Bert Fellows; Jeffrey W Janata; Vidyasagar Pampati; Jay S Grider; Mark V Boswell
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

6.  Trends and sex differences in prescription opioid deaths in British Columbia, Canada.

Authors:  Emilie J Gladstone; Kate Smolina; Steven G Morgan
Journal:  Inj Prev       Date:  2015-07-20       Impact factor: 2.399

Review 7.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

Review 8.  Opioid agonist treatment for pharmaceutical opioid dependent people.

Authors:  Suzanne Nielsen; Briony Larance; Louisa Degenhardt; Linda Gowing; Chyanne Kehler; Nicholas Lintzeris
Journal:  Cochrane Database Syst Rev       Date:  2016-05-09

9.  The burden of premature opioid-related mortality.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; Stephen Cornish; J Michael Paterson; David N Juurlink
Journal:  Addiction       Date:  2014-07-07       Impact factor: 6.526

10.  Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.

Authors:  Leonard J Paulozzi; Karin A Mack; Jason M Hockenberry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-04       Impact factor: 17.586
View more
  19 in total

1.  The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale.

Authors:  M Eugenia Socias; Keith Ahamad; Bernard Le Foll; Ron Lim; Julie Bruneau; Benedikt Fischer; T Cameron Wild; Evan Wood; Didier Jutras-Aswad
Journal:  Contemp Clin Trials       Date:  2018-04-05       Impact factor: 2.226

2.  An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders.

Authors:  M Eugenia Socías; Keith Ahamad
Journal:  CMAJ       Date:  2016-11-07       Impact factor: 8.262

3.  At-a-glance - Concurrent monitoring of opioid prescribing practices and opioid-related deaths: the context in Nova Scotia, Canada.

Authors:  Emily Schleihauf; Kirstin Crabtree; Carolyn Dohoo; Sarah Fleming; Heather McPeake; Matthew Bowes
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-09       Impact factor: 3.240

4.  Been There, Done That: Lessons from Vancouver's Efforts to Stem the Tide of Overdose Deaths.

Authors:  Michael R Krausz; James S H Wong; Ehsan Moazen-Zadeh; Kerry L Jang
Journal:  Can J Psychiatry       Date:  2020-03-16       Impact factor: 4.356

5.  Applying principles of injury and infectious disease control to the opioid mortality epidemic in North America: critical intervention gaps.

Authors:  Benedikt Fischer; Michelle Pang; Mark Tyndall
Journal:  J Public Health (Oxf)       Date:  2020-11-23       Impact factor: 2.341

6.  Upper-Extremity Nerve Decompression Under Local Anesthesia: A Systematic Review of Methods for Reduction of Postoperative Pain and Opioid Consumption.

Authors:  Yehuda Chocron; Albaraa Aljerian; Stephanie Thibaudeau
Journal:  Hand (N Y)       Date:  2019-04-15

7.  Opioid prescribing and dispensing: Experiences and perspectives from a survey of community pharmacists practising in the province of Quebec.

Authors:  Pierre-André Dubé; Julien Vachon; Caroline Sirois; Élise Roy
Journal:  Can Pharm J (Ott)       Date:  2018-10-11

8.  Guideline for opioid therapy and chronic noncancer pain.

Authors:  Jason W Busse; Samantha Craigie; David N Juurlink; D Norman Buckley; Li Wang; Rachel J Couban; Thomas Agoritsas; Elie A Akl; Alonso Carrasco-Labra; Lynn Cooper; Chris Cull; Bruno R da Costa; Joseph W Frank; Gus Grant; Alfonso Iorio; Navindra Persaud; Sol Stern; Peter Tugwell; Per Olav Vandvik; Gordon H Guyatt
Journal:  CMAJ       Date:  2017-05-08       Impact factor: 8.262

9.  Trends in dispensing of individual prescription opioid formulations, Canada 2005-2020.

Authors:  Wayne Jones; Ridhwana Kaoser; David Rudoler; Benedikt Fischer
Journal:  J Pharm Policy Pract       Date:  2022-03-29

10.  Becoming a 'pharmaceutical person': Medication use trajectories from age 26 to 38 in a representative birth cohort from Dunedin, New Zealand.

Authors:  Peri J Ballantyne; Pauline Norris; Venkata Praveen Parachuru; W Murray Thomson
Journal:  SSM Popul Health       Date:  2017-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.